Because FOXM1 is in the PCS1 signature and was reported as a master driver of PCS1 tumors (Ketola et al., 2017), we analyzed the correlation between FOXM1 upregulation and clinical outcomes in PC cohorts. Here, FOXM1 is linked to pachyonychia congenita.